| Dr Jacob B Goldstein, DPM | |
|
230-c East Main St., Gardner, KS 66030-1643 | |
| (913) 856-8150 | |
| (913) 856-8390 |
| Full Name | Dr Jacob B Goldstein |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 34 Years |
| Location | 230-c East Main St., Gardner, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003896374 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Ottawa | Ottawa, KS | Hospital |
| Provider Name | Jacob B Goldstein Dpm Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689967119 PECOS PAC ID: 0244408151 Enrollment ID: O20110720000581 |
News Archive
The plans for a monitoring study on patients being treated with Pentosan Polysulphate (PPS) for CJD and variant CJD have received a favourable opinion from the Eastern Multi-Centre Research Ethics Committee. This follows a provisional opinion from the committee in August.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
Excess dietary vitamin A intake is significantly associated with increased heart valve calcification, show results from an animal study.
The first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients diagnosed with this common cancer in Europe and Australia.
A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jacob B Goldstein, DPM 230-c East Main Street, Gardner, KS 66030-1643 Ph: (913) 856-8150 | Dr Jacob B Goldstein, DPM 230-c East Main St., Gardner, KS 66030-1643 Ph: (913) 856-8150 |
News Archive
The plans for a monitoring study on patients being treated with Pentosan Polysulphate (PPS) for CJD and variant CJD have received a favourable opinion from the Eastern Multi-Centre Research Ethics Committee. This follows a provisional opinion from the committee in August.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
Excess dietary vitamin A intake is significantly associated with increased heart valve calcification, show results from an animal study.
The first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients diagnosed with this common cancer in Europe and Australia.
A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
› Verified 7 days ago
Foot Pain Center Of Kansas City Podiatrist Medicare: Medicare Enrolled Practice Location: 230-c East Main St., Gardner, KS 66030 Phone: 913-856-8150 Fax: 913-856-8390 |